Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endometrial receptivity characteristics in patients with repeated implantation failure: a study using LASSO regression and Bayesian generalized linear model analysis.

Frontiers in medicine·2026
Same author

Mechanisms and effects of ozone-pullulanase treatment on multiscale structures and in vitro digestibility of rice starch.

Food chemistry·2026
Same author

Empagliflozin-pirfenidone dual therapy improves cardiac function and structure in a preclinical two-hit HFpEF model.

Frontiers in pharmacology·2026
Same author

IL-4 peptide hydrogel reprograms MSC heterogeneity toward the CD106+ population for enhanced renal repair.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Pathological Structural Alterations of Serous Cell Cilia in the Parietal Pericardium of Patients With Heart Failure Induced by Dilated Cardiomyopathy.

Reviews in cardiovascular medicine·2026
Same author

Dynamic and Individualized Prediction of Acute Kidney Injury via Longitudinal Peripheral Blood Cell Trajectories among COVID-19 Inpatients: A Multicenter Prospective Cohort Study.

Kidney diseases (Basel, Switzerland)·2026
Same journal

Correction to: Estradiol inhibits vascular endothelial cells pro-inflammatory activation induced by C-reactive protein.

Molecular and cellular biochemistry·2026
Same journal

Galectin-3, transforming growth factor beta 1, and brain natriuretic peptide in cardiac remodeling under hyperlipidemic and hyperglycemic stress.

Molecular and cellular biochemistry·2026
Same journal

Ellagic acid from the traditional Chinese medicinal herb Scutellaria barbata may accelerates apoptosis in hepatic stellate cells during liver fibrosis via inhibiting miR-182-5p.

Molecular and cellular biochemistry·2026
Same journal

GeneQuantify: a web-based tool for qPCR gene expression and copy number variation analysis.

Molecular and cellular biochemistry·2026
Same journal

NCAPG reprograms glycolytic and lipid metabolism by sustaining glycerophospholipid flux in small-cell lung cancer.

Molecular and cellular biochemistry·2026
Same journal

Combination of sitagliptin and mangiferin mitigates testicular damage induced by paclitaxel via mediating Sestrin2/Keap1/Nrf2 signaling pathway.

Molecular and cellular biochemistry·2026
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering
10:18

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering

Published on: September 19, 2011

25.0K

Hydrogels in cardiac tissue engineering: application and challenges.

Yaping Xu1, Yuexin Yu1, Zhikun Guo2,3

  • 1Henan Key Laboratory of Cardiac Remodeling and Transplantation, Zhengzhou Seventh People's Hospital, Henan, 450016, Zhengzhou, People's Republic of China.

Molecular and Cellular Biochemistry
|November 4, 2024
PubMed
Summary
This summary is machine-generated.

Hydrogels offer a promising solution for cardiac tissue engineering, supporting damaged heart tissue and improving function. This approach aims to overcome limitations of current stem cell and transplant therapies for cardiovascular diseases.

Keywords:
Cardiac tissue engineeringDrugs deliveryHeartHydrogelStem cells

More Related Videos

Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications
08:41

Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications

Published on: December 4, 2017

9.0K
Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
09:19

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model

Published on: September 20, 2020

4.4K

Related Experiment Videos

Last Updated: Jun 3, 2026

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering
10:18

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering

Published on: September 19, 2011

25.0K
Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications
08:41

Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications

Published on: December 4, 2017

9.0K
Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
09:19

Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model

Published on: September 20, 2020

4.4K

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Cardiovascular Research

Background:

  • Cardiovascular diseases are the primary cause of global mortality.
  • Current treatments like stem cell therapy and heart transplantation have limitations in long-term cardiac function stability.
  • Cardiac tissue engineering presents a potential strategy for myocardial tissue regeneration.

Purpose of the Study:

  • To review the applications of hydrogels in cardiac tissue engineering.
  • To explore the biomedical mechanisms underlying hydrogel use in cardiac repair.
  • To discuss challenges and propose strategies for the clinical translation of hydrogel-based cardiac therapies.

Main Methods:

  • Literature review of hydrogel applications in cardiac tissue engineering.
  • Analysis of hydrogel properties and functions as scaffolds and carriers.
  • Examination of mechanisms for improving myocardial contractility and microenvironment.

Main Results:

  • Hydrogels provide mechanical support to infarcted myocardium.
  • Hydrogels act as effective carriers for drugs, bioactive factors, and cells.
  • Hydrogels enhance myocardial contractility and improve the cardiac cell microenvironment.

Conclusions:

  • Hydrogels are a viable therapeutic option for cardiac tissue engineering.
  • Addressing clinical translation challenges is crucial for widespread adoption.
  • Hydrogel-based strategies offer new avenues for treating cardiovascular diseases.